In this video interview, Del Smith, PhD, CEO and co-founder of Acclinate, examines the structural and relational barriers ...
In part 1 of this three-part series, behavioral science reveals how slow patient recruitment and enrollment challenges often ...
Thermo Fisher Scientific has completed its acquisition of Clario Holdings for $8.875 billion in cash, plus potential ...
ACT Brief: Thermo Fisher Acquires Clario, Wearables and AI Integration, and Somatic Genomics for IBD
In today's ACT Brief, we examine Thermo Fisher's acquisition of Clario to expand clinical trial data infrastructure, how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results